UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Supply and Clinical Application of Actinium-225 and Bismuth-213

Seminars in nuclear medicine, 2020-03, Vol.50 (2), p.119-123

2020

Volltextzugriff (PDF)

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

European urology, 2021-03, Vol.79 (3), p.343-350

2021

Volltextzugriff (PDF)

New Developments in Peptide Receptor Radionuclide Therapy

Journal of Nuclear Medicine, 2019-02, Vol.60 (2), p.167-171

2019

Volltextzugriff (PDF)

DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy

PloS one, 2014-02, Vol.9 (2), p.e88239

2014

Volltextzugriff (PDF)

Development of Targeted Alpha Therapy from Bench to Bedside

Journal of medical imaging and radiation sciences, 2019-12, Vol.50 (4), p.S18-S20

2019

Volltextzugriff (PDF)

Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?

International journal of molecular sciences, 2023-11, Vol.24 (21), p.15701

2023

Volltextzugriff (PDF)

Magnetic Memory Effect in a Transuranic Mononuclear Complex

Angewandte Chemie (International ed.), 2011-02, Vol.50 (7), p.1696-1698

International ed. in English, 2011

Volltextzugriff (PDF)

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes

Current radiopharmaceuticals, 2012-07, Vol.5 (3), p.221-227

2012

Volltextzugriff (PDF)

Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate

Scientific reports, 2021-03, Vol.11 (1), p.6227-6227, Article 6227

2021

Volltextzugriff (PDF)

Targeted Radiolabeled Compounds in Glioma Therapy

Seminars in nuclear medicine, 2016-05, Vol.46 (3), p.243-249

2016

Volltextzugriff (PDF)

Comparative Analysis of Morphological and Functional Effects of 225Ac- and 177Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands

International journal of molecular sciences, 2023-12, Vol.24 (23), p.16845

2023

Volltextzugriff (PDF)

Antitumor Immunity Induced after α Irradiation

Neoplasia (New York, N.Y.), 2014-04, Vol.16 (4), p.319-328

2014

Volltextzugriff (PDF)

α-Zirconium(IV) Phosphate: Static Study of 225Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using natEu as a Model System for 225Ac

Materials, 2023-08, Vol.16 (17), p.5732

2023

Volltextzugriff (PDF)

Targeted alpha therapy for glioblastoma

Frontiers in medicine, 2022-12, Vol.9, p.1085245-1085245

2022

Volltextzugriff (PDF)

Advances in targeted alpha therapy of cancer

European journal of nuclear medicine and molecular imaging, 2024-04, Vol.51 (5), p.1205-1206

2024

Volltextzugriff (PDF)

PSMA-based alpha therapy in prostate cancer

European journal of nuclear medicine and molecular imaging, 2023-10, Vol.50 (12), p.3506-3508

2023

Volltextzugriff (PDF)

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy

The Journal of nuclear medicine (1978), 2020-01, Vol.61 (1), p.62

2020

Volltextzugriff (PDF)

Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model

Pharmaceuticals (Basel, Switzerland), 2022-05, Vol.15 (5), p.570

2022

Volltextzugriff (PDF)

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma

Oncoimmunology, 2021-01, Vol.10 (1), p.2000699-2000699

2021

Volltextzugriff (PDF)

Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics

EJNMMI research, 2018-08, Vol.8 (1), p.78-6, Article 78

2018

Volltextzugriff (PDF)

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

EJNMMI research, 2017-07, Vol.7 (1), p.57-16, Article 57

2017

Volltextzugriff (PDF)

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction

PloS one, 2015-06, Vol.10 (6), p.e0130249-e0130249

2015

Volltextzugriff (PDF)

Tris-{Hydridotris(1-pyrazolyl)borato}lanthanide Complexes: Synthesis, Spectroscopy, Crystal Structure and Bonding Properties

Inorganics, 2021-06, Vol.9 (6), p.44

2021

Volltextzugriff (PDF)

Quantitative SPECT/CT imaging of actinium-225 for targeted alpha therapy of glioblastomas

EJNMMI physics, 2024-05, Vol.11 (1), p.41-41, Article 41

2024

Volltextzugriff (PDF)

Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer

Molecules (Basel, Switzerland), 2020-02, Vol.25 (5), p.1025

2020

Volltextzugriff (PDF)

1 – 25 von 370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(352)
Mit Volltextzugriff
(339)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(114)
Humans
(91)
Life Sciences & Biomedicine
(90)
Animals
(55)
Oncology
(54)
Mice
(48)
Radioisotopes
(45)
Tumors
(45)
Nuclear Medicine
(44)
Cancer
(39)
Alpha Particles - Therapeutic Use
(37)
Radiology, Nuclear Medicine & Medical Imaging
(37)
Toxicity
(37)
Cell Line, Tumor
(36)
Male
(36)
Medicine
(36)
Female
(35)
Radiology
(35)
Radiation Therapy
(34)
Radioimmunotherapy
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Supply and Clinical Application of Actinium-225 and Bismuth-213

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

New Developments in Peptide Receptor Radionuclide Therapy

DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy

Development of Targeted Alpha Therapy from Bench to Bedside

Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?

Magnetic Memory Effect in a Transuranic Mononuclear Complex

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes

Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate

Targeted Radiolabeled Compounds in Glioma Therapy

Comparative Analysis of Morphological and Functional Effects of 225Ac- and 177Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands

Antitumor Immunity Induced after α Irradiation

α-Zirconium(IV) Phosphate: Static Study of 225Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using natEu as a Model System for 225Ac

Targeted alpha therapy for glioblastoma

Advances in targeted alpha therapy of cancer

PSMA-based alpha therapy in prostate cancer

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy

Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma

Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction

Tris-{Hydridotris(1-pyrazolyl)borato}lanthanide Complexes: Synthesis, Spectroscopy, Crystal Structure and Bonding Properties

Quantitative SPECT/CT imaging of actinium-225 for targeted alpha therapy of glioblastomas

Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer

Suchergebnisse filtern